Skull Base 2011; 21(4): 223-232
DOI: 10.1055/s-0031-1277262

© Thieme Medical Publishers

Transsphenoidal Resection of Sellar Tumors Using High-Field Intraoperative Magnetic Resonance Imaging

Nicholas J. Szerlip1 , Yi-Chen Zhang6 , Dimitris G. Placantonakis1 , 5 , Marc Goldman1 , Kara B. Colevas1 , David G. Rubin1 , 5 , Eric J. Kobylarz2 , Sasan Karimi4 , Monica Girotra3 , Viviane Tabar1
  • 1Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York
  • 2Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York
  • 3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York
  • 4Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York
  • 5Department of Neurological Surgery, Weill Cornell Medical College, New York
  • 6Albert Einstein College of Medicine, Bronx, New York
Further Information

Publication History

Publication Date:
03 May 2011 (online)


There has been increasing experience in the utilization of intraoperative magnetic resonance imaging (iMRI) for intracranial surgery. Despite this trend, only a few U.S centers have examined the use of this technology for transsphenoidal resection of tumors of the sella. We present the largest series in North America examining the role of iMRI for pituitary adenoma resection. We retrospectively reviewed our institutional experience of 59-patients who underwent transsphenoidal procedures for sellar and suprasellar tumors with iMRI guidance. Of these, 52 patients had a histological diagnosis of pituitary adenoma. The technical results of this subgroup were examined. A 1.5-T iMRI was integrated with the BrainLAB (Feldkirchen, Germany) neuronavigation system. The majority (94%) of tumors in our series were macroadenomas. Seventeen percent of tumors were confined to the sella, 49% had suprasellar extensions without involvement of the cavernous sinus, 34% had frank cavernous sinus invasion. All patients underwent at least one iMRI, and 19% required one or more additional sets of intraoperative imaging. In 58% of patients, iMRI led to the surgeon attempting more resection. A gross total resection was obtained in 67% of the patients with planned total resections. There was one case of permanent postoperative diabetes insipidus and no other instances of new hormone replacement. In summary, iMRI was most useful for tumors of the sella with and without suprasellar extension where the information from the iMRI extended the complete resection rate from 40 to 72% and 55 to 88%, respectively. As one would expect, it did not substantially increase the rate of resection of tumors with cavernous sinus invasion. Overall, iMRI was particularly useful in guiding resection safely, aiding in clinical decision making, and allowing identification and preservation of the pituitary stalk and normal pituitary gland. Limitations of the iMRI include a need for additional personnel and training as well as additional operative time, which diminishes over time as personnel learn to optimize workflow efficiency. Additional costs are mitigated in part by using the iMRI as an immediate postoperative scan. Other data emerging from our experience suggest that preservation of normal gland and thus avoidance of hypopituitarism may be improved by iMRI use, but longer follow-up periods are required to test this conclusion. iMRI can detect unsuspected complications sooner than routine postoperative imaging, potentially leading to improved outcomes. However, larger studies are needed.


  • 1 Yeh P J, Chen J W. Pituitary tumors: surgical and medical management.  Surg Oncol. 1997;  6 67-92
  • 2 Kaltsas G A, Evanson J, Chrisoulidou A, Grossman A B. The diagnosis and management of parasellar tumours of the pituitary.  Endocr Relat Cancer. 2008;  15 885-903
  • 3 De Tommasi C, Vance M L, Okonkwo D O, Diallo A, Laws Jr E R. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.  J Neurosurg. 2005;  103 825-830
  • 4 Jagannathan J, Sheehan J P, Pouratian N, Laws Jr E R, Steiner L, Vance M L. Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery.  Neurosurgery. 2008;  62 1262-1269 discussion 1269-1270
  • 5 Cohen-Gadol A A, Liu J K, Laws Jr E R. Cushing's first case of transsphenoidal surgery: the launch of the pituitary surgery era.  J Neurosurg. 2005;  103 570-574
  • 6 Liu J K, Cohen-Gadol A A, Laws Jr E R, Cole C D, Kan P, Couldwell W T. Harvey Cushing and Oskar Hirsch: early forefathers of modern transsphenoidal surgery.  J Neurosurg. 2005;  103 1096-1104
  • 7 Jane Jr J A, Han J, Prevedello D M, Jagannathan J, Dumont A S, Laws Jr E R. Perspectives on endoscopic transsphenoidal surgery.  Neurosurg Focus. 2005;  19 E2
  • 8 Dehdashti A R, Ganna A, Witterick I, Gentili F. Expanded endoscopic endonasal approach for anterior cranial base and suprasellar lesions: indications and limitations.  Neurosurgery. 2009;  64 677-687 discussion 687-689
  • 9 Erdoğan N, Tucer B, Mavili E, Menkü A, Kurtsoy A. Ultrasound guidance in intracranial tumor resection: correlation with postoperative magnetic resonance findings.  Acta Radiol. 2005;  46 743-749
  • 10 Fox W C, Wawrzyniak S, Chandler W F. Intraoperative acquisition of three-dimensional imaging for frameless stereotactic guidance during transsphenoidal pituitary surgery using the Arcadis Orbic System.  J Neurosurg. 2008;  108 746-750
  • 11 Jagannathan J, Prevedello D M, Ayer V S, Dumont A S, Jane Jr J A, Laws E R. Computer-assisted frameless stereotaxy in transsphenoidal surgery at a single institution: review of 176 cases.  Neurosurg Focus. 2006;  20 E9
  • 12 Koc K, Anik I, Ozdamar D, Cabuk B, Keskin G, Ceylan S. The learning curve in endoscopic pituitary surgery and our experience.  Neurosurg Rev. 2006;  29 298-305 discussion 305
  • 13 Rabadán A T, Hernández D, Ruggeri C S. Pituitary tumors: our experience in the prevention of postoperative cerebrospinal fluid leaks after transsphenoidal surgery.  J Neurooncol. 2009;  93 127-131
  • 14 Bohinski R J, Warnick R E, Gaskill-Shipley M F et al.. Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery.  Neurosurgery. 2001;  49 1133-1143 discussion 1143-1144
  • 15 Fahlbusch R, Ganslandt O, Buchfelder M, Schott W, Nimsky C. Intraoperative magnetic resonance imaging during transsphenoidal surgery.  J Neurosurg. 2001;  95 381-390
  • 16 Gerlach R, du Mesnil de Rochemont R, Gasser T et al.. Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases.  Neurosurgery. 2008;  63 272-284 discussion 284-285
  • 17 Nimsky C, von Keller B, Ganslandt O, Fahlbusch R. Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas.  Neurosurgery. 2006;  59 105-114 discussion 105-114
  • 18 Fahlbusch R, Keller B, Ganslandt O, Kreutzer J, Nimsky C. Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging.  Eur J Endocrinol. 2005;  153 239-248
  • 19 Schwartz T H, Stieg P E, Anand V K. Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging.  Neurosurgery. 2006;  58 (1 Suppl) ONS44-ONS51 discussion ONS44-ONS51
  • 20 Theodosopoulos P V, Leach J, Kerr R G et al.. Maximizing the extent of tumor resection during TSS for pituitary mastoadenomas: can endoscopy replace iMRI?.  J Neurosurg. 2010;  112 736-743
  • 21 Nimsky C, Ganslandt O, von Keller B, Fahlbusch R. Intraoperative high-field MRI: anatomical and functional imaging.  Acta Neurochir Suppl (Wien). 2006;  98 87-95
  • 22 Schulder M, Sernas T J, Carmel P W. Cranial surgery and navigation with a compact intraoperative MRI system.  Acta Neurochir Suppl (Wien). 2003;  85 79-86
  • 23 Wu J S, Shou X F, Yao C J et al.. Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging.  Neurosurgery. 2009;  65 63-70 discussion 70-71
  • 24 O'Malley Jr B W, Grady M S, Gabel B C et al.. Comparison of endoscopic and microscopic removal of pituitary adenomas: single-surgeon experience and the learning curve.  Neurosurg Focus. 2008;  25 E10

Viviane TabarM.D. 

Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center

1275 York Avenue, New York, NY 10065